During the last session, Hoth Therapeutics Inc (NASDAQ:HOTH)’s traded shares were 1.07 million, with the beta value of the company hitting 0.83. At the end of the trading day, the stock’s price was $1.36, reflecting an intraday loss of -4.23% or -$0.06. The 52-week high for the HOTH share is $3.80, that puts it down -179.41 from that peak though still a striking 57.35% gain since the share price plummeted to a 52-week low of $0.58. The company’s market capitalization is $9.39M, and the average intraday trading volume over the past 10 days was 50.36 million shares, and the average trade volume was 9.16 million shares over the past three months.
Hoth Therapeutics Inc (HOTH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HOTH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.26.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Hoth Therapeutics Inc (HOTH) registered a -4.23% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.23% in intraday trading to $1.36, hitting a weekly high. The stock’s 5-day price performance is -12.26%, and it has moved by 71.09% in 30 days. Based on these gigs, the overall price performance for the year is 5.43%. The short interest in Hoth Therapeutics Inc (NASDAQ:HOTH) is 0.63 million shares and it means that shorts have 1.16 day(s) to cover.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Statistics show that Hoth Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Hoth Therapeutics Inc (HOTH) shares have gone up 62.00% during the last six months, with a year-to-date growth rate more than the industry average at 48.70% against 16.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.18%. While earnings are projected to return 44.78% in 2025.
HOTH Dividends
Hoth Therapeutics Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Hoth Therapeutics Inc insiders own 0.92% of total outstanding shares while institutional holders control 5.31%, with the float percentage being 5.36%.
Also, the Mutual Funds coming in first place with the largest holdings of Hoth Therapeutics Inc (HOTH) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 38.8 shares. This amounts to just over 0.56 percent of the company’s overall shares, with a $52773.0 market value. The same data shows that the other fund manager holds slightly less at 35.83, or about 0.52% of the stock, which is worth about $48734.0.
